Axsome Therapeutics partecipa a quattro conferenze per investitori
- Axsome Therapeutics interverrà alla Guggenheim 3rd Annual Healthcare Innovation Conference: fireside chat il 9 novembre 2026 a Boston, alle 11:30 ET.
- Incontri con investitori all’8th Annual Wolfe Research Healthcare Conference il 10 novembre 2026 a New York.
- Il 12 novembre 2026 sono previsti incontri con investitori al 2026 Truist BioPharma Symposium a New York.
- Al UBS Global Biopharma Conference 2026 si terrà un fireside chat il 16 novembre 2026 a Londra, alle 11:20 GMT.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire on November 03, 2026, and is solely responsible for the information contained therein.